대한한방내과학회지 (The Journal of Internal Korean Medicine)

대한한방내과학회 (The Society of Internal Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

'항암화학요법을 받은 폐암 환자의 예비 통합의학 임상경로' 개발 및 타당도 평가

Development and Validity Test on Preliminary Critical Pathway of Integrative Medicine for Lung Cancer Patients Treated with Chemotherapy

  • 홍미나 (부산대학교 대학원 한의학과) ;
  • 심소현 (부산대학교 대학원 한의학과) ;
  • 윤성훈 (양산부산대학교병원 호흡기센터) ;
  • 최준용 (부산대학교 한방병원 한의약임상연구센터) ;
  • 김윤성 (양산부산대학교병원 호흡기센터)
  • Hong, Minna (Dept. of Korean Medicine, the Graduate School, Pusan National University) ;
  • Shim, So-hyun (Dept. of Korean Medicine, the Graduate School, Pusan National University) ;
  • Yoon, Seong-hoon (Lung Cancer Clinic, Pulmonary Medicine Center, Pusan National University Yangsan Hospital) ;
  • Choi, Jun-yong (Clinical Research Center for Korean Medicine, Pusan National University Korean Medicine Hospital) ;
  • Kim, Yun-seong (Lung Cancer Clinic, Pulmonary Medicine Center, Pusan National University Yangsan Hospital)
  • 투고 : 2017.10.31
  • 심사 : 2017.12.27
  • 발행 : 2017.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: The objective of this study was to investigate the validity of the preliminary critical pathway of integrative medicine to improve the quality of life of lung cancer patients who received chemotherapy. Methods: The vertical axis of the preliminary critical pathway of integrated medicine consisted of nine domains: assessment, treatment, activity, consult, diet, medication, Korean medical examination, education, and others. The frame of the horizontal axis was the date from hospitalization to discharge. A total of 105 items in this preliminary critical pathway were validated by an expert group from October 28, 2016 to November 4, 2016. A total of ten experts from two different medical institutions participated in the validity test, using the four-point Content Validity Index (CVI) scale. The items with validity of greater than 80% were considered as significant. Results: The analysis of the content validity of 105 items showed 102 items with greater than 80% agreement. Assessment, treatment, consult, diet, medication, and education showed 100% agreement. Only three items showed a low validity (62.5%). Based on additional comments, the preliminary critical pathway of integrative medicine has been supplemented. Conclusions: This study suggests the possibility of using the integrated medical critical pathway for patients with lung cancer who received chemotherapy.

키워드

참고문헌

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61(2):69-90. https://doi.org/10.3322/caac.20107
  2. Kim YH, Kim YT, Kim HK, Park IG, Wu HG, Song SY, et al. Lung cancer guideline. Korean Association for Lung Cancer 2010.
  3. Park KC. Chemotherapy in Lung Cancer. Seoul: The Korean Medical Association; 2003, p. 38-45.
  4. Pisters KM, Le Chevalier T. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. J Clin Oncol 2005;23(14):3270-8. https://doi.org/10.1200/JCO.2005.11.478
  5. Hong MN. Change of the Quality of Life among Lung Cancer Patients Treated with Chemotherapy and Development of Critical Pathway of Integrative Medicine. Pusan National University 2017.
  6. Shim JK, Kwon HJ, Jung MK, Oh JM, Park SH, Shin KM, et al. Fatigue and its Related Factors in Lung Cancer Patients on Chemotherapy. The chung-Ang Journal of Nursing 2003;7(1):9-15.
  7. Lim KT, Heo I, Kim BJ, Shin BC, Son DW, Kim CY, et al. The Survey on Contents Validity of 'Preliminary Critical Pathway for Acute Postoperative Pain after Back Surgery'. J Korean Med Rehabil 2016;26(4):77-83. https://doi.org/10.18325/jkmr.2016.26.4.77
  8. Kim SA. Development of CP (Critical Pathway) System for women's cancer patients Receiving Chemotherapy. The Graduate School, Yonsei University 2006.
  9. Kim MJ, Lee JA, Song HS, Kim ES, Yeon MJ, Cho SH, et al. The Development of the Critical Pathway and Nursing Record for Patients received FP Chemotherapy. Korean J Adult Nurs 1999;11(4):845-57.
  10. Choi JY, Jang KS, Choi EY. Development of a Critical Pathway for the Chemotherapy of Non-small Cell Lung Cancer Patients and Its Effects. J Korean Acad Nurs Adm 2002;8(1):85-95.
  11. Kwon SM. development of critical pathway for patirnt with meningioma resection. Ulsan University Graduate School of Industry 2004.
  12. Kim SY. Development of Critical Pathway for Gamma Knife Surgery Patients. Graduate School of Public Administration, Hanyang University 2005.
  13. Kim JA. Development of a Critical Pathway for patients with Deviation of Nasal Septum. Kyung Hee University School of Education 2013.
  14. Yang SY. Development of Clinical Application Program and Construction of Critical Pathways for Surgical Preventive Antibiotics Use. Konyang University 2016.
  15. Yong MS. Development of critical pathway for the patient with microdiscectomy. HanLim University 2008.
  16. Jang YS. Development of a critical pathway for patients with malignant lymphoma. Yonsei University School of Health 2004.
  17. Choe MJ. Development of Critical Pathway toward ketogenic diet cure for children epilepsy cases. Yonsei University Graduate School of Nursing 2011.
  18. Han SY. Development and effects of critical pathway for Coronary Artery Bypass Grafting (CABG). Yonsei University School of Health 2005.
  19. Hong SH. Development of a critical pathway for the patients undergoing anterior cervical discectomy and fusion. Yonsei University Graduate School of Nursing 2010.
  20. Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26(21):3552-9. https://doi.org/10.1200/JCO.2007.13.9030
  21. Lee N, Kim KH, Lee SC. Oral chemotherapeutic agents in current use. J Korean Med Assoc 2011;54(11):1191-8. https://doi.org/10.5124/jkma.2011.54.11.1191
  22. Kwon HK, Kim JS, Yu HS. Review for the Status of Cancer Complementary and Alternative Medicine in the World. J Korean Tradit Oncol 2009;14(1):1-11.
  23. Lee EO, Lee MS, Heo DS, Lee KS, Eom AY. Trajectories and related Factors of Fatigue in Patients Undergoing Chemotherapy for Lung Cancer. J Korean Oncol Nurs 2001;1(1):54-64.
  24. Kim MH, Kang PS, Lee KS, Hwang TY, Maxwell AE. Utilization of Complementary and Alternative Medicine of Cancer Patient in Korea. J Agr Med Community Health 2007;32(3):155-67. https://doi.org/10.5393/JAMCH.2007.32.3.155
  25. Chang SB, Lee TW, Kim SYJ, Yoo IY, Kim IS, Kang KH, et al. A Study of Complementary and Alternative Medicine used by Cancer Patients in Korea. The Korean Academic Society Of Adult Nursing 2006;18(1):92-101.
  26. Jeong GS. Experiences and attitudes of lung cancer patients receiving complementary and alternative therapies. Kosin University graduate school 2006.
  27. Choi YJ, Lee JS, Cho SH. Use of Korean Medicine among Cancer Patients. J Korean Oriental Med 2012;33(3):46-53.
  28. Kim DH, Jeon DS, Park SC, Lee SE, Cho WH, Han CW, et al. Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients - A single group before-and-after, preliminary study -. Journal of physiology &pathology in Korean Medicine 2014;28(1):82-8.
  29. Seong YS, Cho EY, Lee YS, Yang HL, Lee HJ. Effects of Nei-Guan Acupressure on Chemotherapyrelated Nausea, Vomiting, and Anorexia in Patients with Lung Cancer. Journal of East-West Nursing Research 2010;16(1):1-10.
  30. Iwase S, Yamaguchi T, Miyaji T, Terawaki K, Inui A, Uezono Y. The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients' symptoms in Japan: a national cross-sectional survey. BMC Complement Altern Med 2012;12:222. https://doi.org/10.1186/1472-6882-12-S1-P222
  31. Kasymjanova G, Grossman M, Tran T, Jagoe RT, Cohen V, Pepe C, et al. The potential role for acupuncture in treating symptoms in patients with lung cancer: an observational longitudinal study. Curr Oncol 2013;20(3):152-7. https://doi.org/10.3747/co.20.1312

피인용 문헌

  1. Systematic Review of Case Reports about Korean Medicine for Lung Cancer vol.39, pp.4, 2017, https://doi.org/10.13048/jkm.18041
  2. 폐암 한약제제 임상시험 가이드라인 개발을 위한 한약제제 무작위배정 대조군 임상시험 고찰 vol.40, pp.1, 2017, https://doi.org/10.13048/jkm.19012
  3. 중풍 입원 환자 관리를 위한 임상경로 개발 vol.42, pp.2, 2017, https://doi.org/10.13048/jkm.21015